Alkermes to Take Part in the Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on September 29, 2021, at 8:40 a.m. ET. Investors can access the presentation via the Investors tab on www.alkermes.com, where it will be archived for 14 days. Alkermes is a global biopharmaceutical company focused on neuroscience and oncology, with products related to addiction and various mental health disorders.

Positive

• Participation in a major healthcare conference may enhance visibility among investors.
• Opportunity to present innovative medicines in neuroscience and oncology sectors.

Negative

• None.

DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 29, 2021 at 8:40 a.m. ET (1:40 p.m. BST). The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-cantor-virtual-global-healthcare-conference-301382411.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Cantor Virtual Global Healthcare Conference?

Alkermes will participate in the conference on September 29, 2021, at 8:40 a.m. ET.

What is the significance of the Cantor Virtual Global Healthcare Conference for Alkermes?

The conference provides Alkermes an opportunity to increase visibility and discuss its innovative medicines with investors.

How can investors access Alkermes' presentation at the conference?

Investors can access the presentation via the Investors tab on www.alkermes.com.

How long will Alkermes' presentation be archived?

The presentation will be archived for 14 days.

What areas does Alkermes focus on in its drug development?

Alkermes focuses on neuroscience and oncology, particularly in addiction and mental health disorders.